Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.9k Views
Introducing Long Term Leaders - Focussed Insights for your Core Holdings
We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category, we have identified companies that...
497 Views
[Japan Activism/M&A] Hogy Medical (3593) Reportedly Up For Auction - Totally Unsurprising
After a BBG article on 9 Dec and a Nikkei article this weekend sending Hogy Medical limit up y/day, this AM Hogy says Carlyle has bid ¥6700/share...
1.2k Views
Medical Data Vision (3902 JP): Nippon Life’s Tender Offer at JPY1,693 (3x Last Close)
The substantial takeover premium reflects the outcome of an auction and SBI Holdings' willingness to share TOB tax benefits with minority...
530 Views
Medical Data Vision (3902 JP): Nippon Life’s Rumoured Tender Offer at 3x the Last Close
The Nikkei reports that Nippon Life will launch a tender offer at a valuation of JPY60bn. If the valuation refers to market cap, the offer is...
541 Views